These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15598693)

  • 21. Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver.
    Targher G; Pichiri I; Zoppini G; Trombetta M; Bonora E
    Diabet Med; 2012 Feb; 29(2):220-6. PubMed ID: 21883436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Gambarin-Gelwan M; Kinkhabwala SV; Schiano TD; Bodian C; Yeh HC; Futterweit W
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):496-501. PubMed ID: 17287148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
    Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic steatohepatitis and insulin resistance: interface between gastroenterologists and endocrinologists.
    Scheen AJ; Luyckx FH
    Acta Clin Belg; 2003; 58(2):81-91. PubMed ID: 12836490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
    Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
    Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus infection and fatty liver in the general population.
    Wong VW; Wong GL; Chu WC; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Chan HY; Woo J; Chan FK; Chan HL
    J Hepatol; 2012 Mar; 56(3):533-40. PubMed ID: 22027575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
    Guaraldi G; Lonardo A; Ballestri S; Zona S; Stentarelli C; Orlando G; Carli F; Carulli L; Roverato A; Loria P
    Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolic syndrome and insulin resistance in patients with chronic hepatitis C].
    Baĭzhanova ZhZh; Ignatova TM; Nekrasova TP
    Ter Arkh; 2010; 82(10):51-6. PubMed ID: 21341465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics of health screen examinees with nonalcoholic fatty liver and normal liver function test].
    Lee SY; Kim SK; Kwon CI; Kim MJ; Kang MS; Ko KH; Hong SP; Hwang SG; Park PW; Rim KS
    Korean J Gastroenterol; 2008 Sep; 52(3):161-70. PubMed ID: 19077512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.
    Mohan V; Farooq S; Deepa M; Ravikumar R; Pitchumoni CS
    Diabetes Res Clin Pract; 2009 Apr; 84(1):84-91. PubMed ID: 19168251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.
    Dâmaso AR; do Prado WL; de Piano A; Tock L; Caranti DA; Lofrano MC; Carnier J; Cristofalo DJ; Lederman H; Tufik S; de Mello MT
    Dig Liver Dis; 2008 Feb; 40(2):132-9. PubMed ID: 18082476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
    Kieć-Wilk B; Klupa T; Dembińska-Kieć A
    Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome.
    Cheung O; Kapoor A; Puri P; Sistrun S; Luketic VA; Sargeant CC; Contos MJ; Shiffman ML; Stravitz RT; Sterling RK; Sanyal AJ
    Hepatology; 2007 Oct; 46(4):1091-100. PubMed ID: 17610277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
    Hamaguchi M; Kojima T; Itoh Y; Harano Y; Fujii K; Nakajima T; Kato T; Takeda N; Okuda J; Ida K; Kawahito Y; Yoshikawa T; Okanoue T
    Am J Gastroenterol; 2007 Dec; 102(12):2708-15. PubMed ID: 17894848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.